שליחת רשומה: HTRS2025.P1.2 Effect of Baseline Target Joints on Annualized Bleeding Rate and Management of Breakthrough Bleeding in Patients With Hemophilia A or B and Inhibitors: Results From Concizumab Phase 3 Explorer7